ANTICOAGULACION EN PACIENTES CON INSUFICIENCIA CARDIACA
Columnista Experta de SIIC Ferruccio De Lorenzo
en colaboración con
Olena Dotsenko , MD, Thrombosis Research Insitute
Fecha de aprobación: 23 de junio, 2005
Primera edición en siicsalud:
27 de febrero, 2006
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/74820
Especialidad principal:
Cardiología
Hematología
Especialidades relacionadas:
Medicina Farmacéutica,Medicina Interna,
De Lorenzo F, Xiao H, Kadziola Z, Scully M, Kakkar VV. Risk of recurrent thrombotic events in patients with coronary heart disease and left ventricular dysfunction, Int J Cardiol 89(89):93-93, 2003
De Lorenzo F, Xiao H, Scully M, Kadziola Z, Kakkar VV. Pre-thrombotic state and impaired fibrinolytic potential in CHD patients with left ventricular dysfunciton, Blood Coagulation & Fibrinolysis 14:67-75, 2003
De Lorenzo F, Saba N, Dancy M, Kadziola Z, Kakkar VV, Xiao HB. Induced ischemia detected by dobutamine stress echocardiogrphy in CHD patients after myocardial re-vascularization. Experience in a Disctrict General Hospital, Int J Cardiol 83(83):119-124, 2002
De Lorenzo F, Newberry D, Scully M, Kadziola Z, Dawson G, Ranlall N, Saba N, Noorani A, Kashani S, Williams R, Kakkar VV. Low molecular weight heparin (LMWH) (Bemiparin Sodium 3,500 IU) on the regulation profile of patients with hearth failure, Am Heart J 143(143):689, 2002
Kakkar VV, Iyengar SS, De Lorenzo F, Hargreaves JR, Kadziola ZA; on behalf of the FAMI Investigator Group. Low-molecular wigth heparin for treatment of acute myocardial infarction FAMI: Fragmin (Dalteparin Sodium) in acute myocardial infarction, Indian Heart Journal 52(52):533-539, 2002
De Lorenzo F, Xiao H, Kakkar VV. Prognostic role of plasminogen-activator-inhibitor-1 (PAI-1) levels in treatment with streptokinase of patients with acute myocardial infarction, Clin Cardiol 23:877-878, 2000
Ferruccio De Lorenzo
